Product Images Terbinafine Hydrochloride

This is a report on adverse events for a medication trial involving Lamisit and placebo. The report includes the number and percentages of patients who experienced certain symptoms while taking the medication. The symptoms are categorized as Headache, Gastrointestinal Symptoms (including diarrhea, dyspepsia, abdominal pain, nausea, and flatulence), Dermatological Symptoms (including rash, pruritus, and urticaria), and Abnormal Liver Enzymes. Taste disturbance and Visual Disturbance were also reported. One patient had liver enzyme abnormalities that were 22 times the upper limit of normal range.*

This is a list of symptoms that includes nausea, stomach pain, rash, headache, vomiting, dizziness, and frequent urination. It may indicate a medical condition that requires further evaluation and diagnosis by a healthcare professional.*

This appears to be a list of symptoms related to liver dysfunction such as jaundice, upper right abdominal pain, dark urine, and pale or light colored stools. Other common symptoms include nausea, poor appetite, tiredness, and vomiting. If you are experiencing these symptoms, it is important to seek medical attention as soon as possible.*

This is the information for the drug Terbinafine Hydrochloride, which is available in the form of tablets of strength 250mg. The drug is used for treating certain types of fungal infections. The prescription label and the package insert should be referred to for details regarding dosage information. The tablets should be stored between 20°C to 25°C with protection from light. The manufacturer of the drug is Camber Pharmaceuticals Inc. located in Piscataway, NJ, and it is manufactured by InvaGen Pharmaceuticals Inc. located in Hauppauge, NY.*